drugset

drugset / Trial / NCT05347069

Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization

NCT05347069 ↗

Phase 4 Recruiting 2890 enrolled Takeshi Morimoto

RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to evaluate the efficacy and safety aspirin in patients with chronic coronary syndromes without revascularization.

Timeline

Start: 2022-06-14
Primary completion: 2030-03
Completion: 2030-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Aspirin	Small molecule	100 mg	—

Indications